Martin Shrkeli's Turing reneges on cut to $750-a-pill price

Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price for Daraprim, which treats a rare parasitic infection.

from CBC | Health News http://ift.tt/21gCiiG